SCHEMBL32688258

SCHEMBL32688258

N#Cc1c(Cc2ccccc2)nc(=O)[nH]c1SCc1nnn[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 4/20 0.38
▸ ACMSD Q8TDX5 2/20 0.38
▸ CTSB P07858 4/20 0.38
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ POLB P06746 3/20 0.37
▸ CXCR2 P25025 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ FPR1 P21462 1/20 0.35
▸ RAPGEF4 Q8WZA2 1/20 0.35
▸ HSD11B2 P80365 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24087923 0.83 ACMSD (0.53) HSD11B1ACMSDMEN1KMT2APOLB
SCHEMBL32688366 0.83 ACMSD (0.47) HSD11B1ACMSDMEN1KMT2APOLB
SCHEMBL32688468 0.81 MAT2A (0.42) HSD11B1ACMSDCTSBMEN1KMT2A
SCHEMBL32688228 0.78 HSD11B1 (0.40) HSD11B1MEN1KMT2APOLBCXCR2
SCHEMBL32688043 0.76 LMNA (0.45) HSD11B1ACMSDMEN1KMT2APOLB
SCHEMBL32688407 0.76 ACMSD (0.39) HSD11B1ACMSDMEN1KMT2APOLB
SCHEMBL32688268 0.75 MEN1 (0.42) HSD11B1ACMSDMEN1KMT2APOLB
SCHEMBL32688388 0.75 KDM4E (0.33) MEN1KMT2AKDM4E
SCHEMBL32688253 0.75 CXCR2 (0.36) MEN1KMT2APOLBCXCR2
SCHEMBL32688157 0.75 MEN1 (0.46) HSD11B1MEN1KMT2APOLBCXCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK HSD11B1 61/4885ACMSD 142/4885CTSB 1942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback